Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Lowered to $29.00 at Wedbush
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its price objective reduced by equities research analysts at Wedbush from $30.00 to $29.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Wedbush’s price objective would indicate a potential upside of 15.77% from the stock’s […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its price objective reduced by equities research analysts at Wedbush from $30.00 to $29.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Wedbush’s price objective would indicate a potential upside of 15.77% from the stock’s […]
